Product
AlloSeq
1 clinical trial
1 indication
Indication
Kidney Transplant RejectionClinical trial
The Efficacy of Donor-derived Cell-free DNA as a Biomarker for Subclinical Antibody-mediated Rejection in de Novo Anti-HLA DSA-positive Recipients Who Maintain Stable Renal Function After Kidney TransplantationStatus: Recruiting, Estimated PCD: 2024-11-30